Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15(12):1257–1272. https://doi.org/10.1016/S1474-4422(16)30230-7
Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R (2007) How common are the common neurologic disorders? Neurology 68(5):326–337. https://doi.org/10.1212/01.WNL.0000252807.38124.A3
Article PubMed CAS Google Scholar
Isaacson SH (2019) Early Recognition and diagnosis of Parkinson Disease and Ongoing assessments. J Clin Psychiatry 81(1):27645. https://doi.org/10.4088/JCP.MS18003BR1C
DeMaagd G, Philip A (2015) Parkinson’s Disease and its management: part 1: Disease Entity, Risk factors, pathophysiology, clinical presentation, and diagnosis. Pharm Ther 40(8):504
Gray R, Ives N, Rick C et al (2014) Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet (London England) 384(9949):1196–1205. https://doi.org/10.1016/S0140-6736(14)60683-8
Article PubMed CAS Google Scholar
Fox SH, Katzenschlager R, Lim SY et al (2011) The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):SUPPL3. https://doi.org/10.1002/MDS.23829
Okun MS, Zeilman PR (2014) (U.S.) NPF. Parkinson’s Disease: deep brain stimulation a practical guide for patients and families. National Parkinson Foundation, Incorporated
Limousin P, Pollak P, Benazzouz A et al (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (London England) 345(8942):91–95. https://doi.org/10.1016/S0140-6736(95)90062-4
Article PubMed CAS Google Scholar
Follett KA, Weaver FM, Stern M et al (2010) Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 362(22):2077–2091. https://doi.org/10.1056/NEJMOA0907083
Article PubMed CAS Google Scholar
Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP (2005) Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 62(4):554–560. https://doi.org/10.1001/ARCHNEUR.62.4.554
Weaver FM, Follett K, Stern M et al (2009) Bilateral deep brain stimulation vs Best Medical Therapy for patients with Advanced Parkinson Disease: a Randomized Controlled Trial. JAMA 301(1):63–73. https://doi.org/10.1001/JAMA.2008.929
Article PubMed PubMed Central CAS Google Scholar
Feng C, Wu Y, Gao L, Guo X, Wang Z, Xing B (2019) Publication Landscape Analysis on gliomas: how much has been done in the past 25 years? Front Oncol 9:1463. https://doi.org/10.3389/FONC.2019.01463
Zhang H, Fan Y, Wang R et al (2020) Research trends and hotspots of high tibial osteotomy in two decades (from 2001 to 2020): a bibliometric analysis. J Orthop Surg Res 15(1). https://doi.org/10.1186/S13018-020-01991-1
Liu W, Wu J, Zhang N et al (2023) Postural deformities in Parkinson’s disease: a bibliometric analysis based on web of science. Heliyon 9(3):e14251. https://doi.org/10.1016/J.HELIYON.2023.E14251
Article PubMed PubMed Central Google Scholar
van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523–538. https://doi.org/10.1007/S11192-009-0146-3/FIGURES/7
Kirby A (2023) Exploratory Bibliometrics: Using VOSviewer as a Preliminary Research Tool. Publ. 11(1):10. https://doi.org/10.3390/PUBLICATIONS11010010
Lin A, Mai X, Lin T et al (2022) Research Trends and hotspots of Retinal Optical Coherence Tomography: a 31-Year bibliometric analysis. J Clin Med 11(19):5604. https://doi.org/10.3390/JCM11195604/S1
Article PubMed PubMed Central Google Scholar
Chen C (2016) CiteSpace: A Practical Guide for Mapping Scientific Literature.
Eisinger RS, Okun MS, Cernera S et al (2023) Weight and survival after deep brain stimulation for Parkinson’s disease. Park Relat Disord 115. https://doi.org/10.1016/J.PARKRELDIS.2023.105810
Merner AR, Kostick-Quenet K, Campbell TA et al (2023) Participant perceptions of changes in psychosocial domains following participation in an adaptive deep brain stimulation trial. Brain Stimul 16(4):990–998. https://doi.org/10.1016/J.BRS.2023.06.007
Article PubMed PubMed Central Google Scholar
Allen WL, Giordano J, Okun MS (2023) DBS-Induced changes in personality, Agency, Narrative and Identity. AJOB Neurosci 14(3):300–302. https://doi.org/10.1080/21507740.2023.2243865
Soh D, Maciel R, Algarni M et al (2021) Flexible vs. standard subthalamic stimulation in Parkinson disease: a double-blind proof-of-concept cross-over trial. Park Relat Disord 89:93–97. https://doi.org/10.1016/J.PARKRELDIS.2021.07.003
Picillo M, Phokaewvarangkul O, Poon YY et al (2021) Levodopa Versus dopamine agonist after subthalamic stimulation in Parkinson’s Disease. Mov Disord 36(3):672–680. https://doi.org/10.1002/MDS.28382
Article PubMed CAS Google Scholar
Voon V, Krack P, Lang AE et al (2008) A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain 131(10):2720–2728. https://doi.org/10.1093/BRAIN/AWN214
Article PubMed PubMed Central Google Scholar
Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E (2011) Ten-year outcome of Subthalamic Stimulation in Parkinson Disease: a blinded evaluation. Arch Neurol 68(12):1550–1556. https://doi.org/10.1001/ARCHNEUROL.2011.182
Bronstein JM, Tagliati M, Alterman RL et al (2011) Deep brain stimulation for Parkinson Disease: An Expert Consensus and Review of Key issues. Arch Neurol 68(2):165–165. https://doi.org/10.1001/ARCHNEUROL.2010.260
Lang AE, Gill S, Patel NK et al (2006) Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59(3):459–466. https://doi.org/10.1002/ANA.20737
Article PubMed CAS Google Scholar
Okun MS, Gallo BV, Mandybur G et al (2012) Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol 11(2):140–149. https://doi.org/10.1016/S1474-4422(11)70308-8
Okun MS, Fernandez HH, Wu SS et al (2009) Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 65(5):586–595. https://doi.org/10.1002/ANA.21596
Article PubMed PubMed Central Google Scholar
Stefani A, Lozano AM, Peppe A et al (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130(6):1596–1607. https://doi.org/10.1093/BRAIN/AWL346
Rodriguez-Oroz MC, Obeso JA, Lang AE et al (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128(10):2240–2249. https://doi.org/10.1093/BRAIN/AWH571
Article PubMed CAS Google Scholar
Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 53(1):85–85. https://doi.org/10.1212/WNL.53.1.85
Article PubMed CAS Google Scholar
Moro E, Lozano AM, Pollak P et al (2010) Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov Disord 25(5):578–586. https://doi.org/10.1002/MDS.22735
Vercueil L, Pollak P, Fraix V et al (2001) Deep brain stimulation in the treatment of severe dystonia. 248(8):695–700. https://pubmed.ncbi.nlm.nih.gov/11569899/ Accessed November 26, 2023
Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601. https://doi.org/10.1002/MDS.26424
Deuschl G, Schade-Brittinger C, Krack P et al (2006) A Randomized Trial of Deep-Brain Stimulation for Parkinson’s Disease. 355(9):896–908.
留言 (0)